“Durability of Efficacy and Safety of Roflumilast Cream 0.3% in Adults With Chronic Plaque Psoriasis From a 52-Week, Phase 2 Open-Label Safety Trial”. SKIN The Journal of Cutaneous Medicine 7, no. 4 (July 17, 2023): s218. Accessed April 18, 2025. https://skin.dermsquared.com/skin/article/view/2194.